论文部分内容阅读
2016年12月巴西心脏协会发布最新一版的心房颤动(简称房颤)指南执行纲要,这是自该协会2009年第一次发布房颤指南执行纲要后,时隔8年再次修订并发布新版房颤指南执行纲要[1]。本次指南主要提出:(1)准许增加口服抗凝药用于临床;(2)扩展了非药物治疗特别是射频消融的手术指征。也正是这些原因修订了房颤指南。该指南首先介绍了房颤的流行病学变化,并指出在过去20年,房颤已经成为一个公共卫生问题
December 2016 The Brazilian Heart Association released the latest version of the guidelines for the implementation of the guidelines for atrial fibrillation (atrial fibrillation), which was revised and released anew eight years after its first implementation of the guidelines for atrial fibrillation in 2009 Atrial fibrillation guidelines executive summary [1]. This guideline mainly states: (1) Permitting the addition of oral anticoagulants for clinical use; and (2) Extending the indications for non-medical treatment, especially radiofrequency ablation. It is also these reasons revised atrial fibrillation guidelines. The guide begins with an introduction to the epidemiological changes of atrial fibrillation and points out that in the past 20 years, atrial fibrillation has become a public health issue